2ESPOSITO V, BALDI A, DE LUCA A, et al. Cell cycle related proteins as prognostic parameters in radically resected nonsmall cell lung cancer[J]. J Clin Pathol, 2005,58(7):734-739.
3AI L, STEPHENSON K K, LING W, et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases[J]. Mod Pathol, 2003,16(9):944-950.
4SARIDAKI Z, LILOGLOU T, ZAFIROPOULOS A, et al. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin[J]. Br J Dermatol, 2003,148(4):638-648.
6AHOMADEGB J C, BARROIS M, FOGEL S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases: absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early noninvasive lesions[J]. Oncogene, 1995,10(6):1217-1227.
3[1]Bos JL. ras oncogene in human cancer[J]. Review Cancer Res 1984;49:4862.
4[2]Lane DP,Crawford LV. T-antigen is bound to a host protein in SV40 transformed cells [J]. Nature 1979; 278: 261.
5[3]Pandidos DA, Kerr IB. Elevated expression of the tumor ras oncogene family in premalignant and malignant tumors of the colorectum[J]. Br J Cancer 1984;49(3):681.
6[4]Kastan MB,Onyekwere O,Sidransky D, et al. Participation of p53 protein in the cellular response to DNA damage[J]. Cancer Res 1991 ;51:6304.
7[5]Heid I,Theide C, Sonntag T,et al. The status of p53 in the metastatic progression of colorectal cancer [J]. Eur J Cancer 1997;33(8):1314.
8[6]Ahnen DJ,Feigl P,Quan G,et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer[J].Cancer Res 1998; 58(6):1149.
9[7]Hinds P,Finally C,Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation [J]. JVirol 1989;63:739.
5KIEGER J, ALEXANDER A, FARACH-CARSON M C. Type I collagen-mediated changes in gene expression and function of prostate cancer cells[J]. Cancer Treat Res, 2004, 118: 101-124.
6KIEFER J A, FARACH-CARSON M C. Type I collagenmediated proliferation of PC3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment [J]. Matrix Biol, 2001,20(7) : 429-437.
7DAHLMAN T, LAMMERTS E, BERGSTROM D, et al. Collagen type I expression in experimental anaplastic thyroid carcinoma: regulation and relevance for tumorigenicity[J]. Int J Cancer, 2002,98(2) : 186-192.
8SENGUPTA P K, SMITH E M, KIM K, et al. DNA hypermethylation near the transcription start site of collagen alpha2 ( I ) gene occurs in both cancer cell lines and primary colorectal cancers[J]. CancerRes, 2003,63(8) :1789-1797.
9RENE F M, RUND P, MICHAEL G. Prognostic significance of type IV collagen and immunoreaetity IV inurothellal carcinoma of the bladder[J].Cancer J, 1990,12:2583-2586.
10GOROGH T, MAUNE S, LIPPERT B M, et al. Transcriptional repression of the human fibronectin gene in laryngeal squamous cell carcinoma cells[J]. J Cancer Res Clin Oncol, 2001,127(3) : 166-172.
